title: Influence of the treatment with recombinant human erythropoietin on plasma concentration of interleukin-1-alpha and tumour necrosis factor-alpha in hemodialyzed subjects.
authors.forename: M
authors.initials: M
authors.lastname: Buemi
authors.forename: A
authors.initials: A
authors.lastname: Allegra
authors.forename: C
authors.initials: C
authors.lastname: Aloisi
authors.forename: M
authors.initials: M
authors.lastname: Privitera
authors.forename: N
authors.initials: N
authors.lastname: Morabito
authors.forename: N
authors.initials: N
authors.lastname: Frisina
mesh_terms: D000740:Anemia / Q000097:blood / Q000188:drug therapy; D004921:Erythropoietin / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007375:Interleukin-1 / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha; D004921:Erythropoietin